Cytopathologic and Molecular Diagnostic Clues to Poorly Differentiated Thyroid Carcinoma: A 10-Year Single Institution Experience
Liying Fu, Xiangbai Chen, Berrin Ustun, Julie Ann Sosa, Sanziana Roman, Elizabeth Holt, Manju Prasad, Adebowale Adeniran, David Chhieng, Renu Virk, Constantine Theoharis. Yale-New Haven Hospital, New Haven, CT
Background: Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid neoplasm with clinical behavior between differentiated thyroid carcinoma and anaplastic thyroid carcinoma. PDTC often displays insular architecture, necrosis and increased mitotic activity on histopathologic evaluation. However, there are few studies describing cytological features of this rare tumor, which are important for a preoperative diagnosis. In this retrospective study, we review our experience in the fine needle aspiration (FNA) diagnosis of PDTC.
Design: Cases of PDTC were collected from our archives, a tertiary referral hospital, between the years 2002-2012. Of 21 cases surgically diagnosed as PDTC, 16 patients had preoperative FNA evaluation and were included in this study. Four cases had BRAF mutation analysis in addition to cytological evaluation. These cases were retrospectively reviewed by two cytopathologists.
Results: Eleven patients were men and five were women. The mean age was 56 years, ranging from 22 to 70 years. The original cytological diagnoses (16 patients) were as follows: 1 “benign” (FNA performed on one calcified nodule contralateral to eventual malignancy), 7 follicular neoplasm, 2 positive for malignancy-NOS, 4 papillary thyroid carcinoma (PTC) and 2 PDTC. Nine cytological specimens were available for review, the cytological features of which were listed in Table 1. Four cases were tested for BRAF mutation; all were negative.
|Cytomorphological features||Case numbers (n)||Percentage (%)|
|Absence of colloid||7||77.8|
|Numerous single cells||6||66.7|